FILE PHOTO: French multinational pharmaceutical company SANOFI logo is seen at the headquarters in Paris, France, March 8, 2016. REUTERS/Philippe Wojazer/File Photo (Reuters) – A potent, expensive cholesterol drug sold by Regeneron Pharmaceuticals and Sanofi s... More »
(Reuters) – Regeneron Pharmaceuticals Inc and Sanofi SA said on Saturday they would be willing to charge less for their potent cholesterol drug, Praluent, if insurers agree to lessen onerous access barriers for high-risk patients. Since the approvals in 2015 o... More »
Gridlock traffic is pictured on highway 395 as people evacuate Washington after an earthquake August 23, 2011. REUTERS/Jason Reed By Lisa Rapaport(Reuters Health) – People who live near sources of heavy traffic exhaust may be at higher risk of heart disease be... More »
FILE PHOTO – An Amgen sign is seen at the company’s office in South San Francisco, California, U.S. on October 21, 2013. REUTERS/Robert Galbraith/File Photo Amgen Inc’s (AMGN.O) $14,000 cholesterol drug Repatha cut the risk of heart attack and stroke by over 2... More »
Data that should help unlock the sales potential of a potent new cholesterol medicine will be unveiled at the American College of Cardiology meeting this week as the future of the only rival drug rests with the courts in an ongoing patent dispute. More »
An Amgen sign is seen at the company’s office in South San Francisco, California October 21, 2013. REUTERS/Robert Galbraith Regeneron Pharmaceuticals Chief Executive Len Schleifer on Monday ripped into Amgen Inc for its insistence on blocking sales of a rival ... More »
We use cookies!
By using this site you agree to the use of cookies, more info.